Cargando…
Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects
Sarcoidosis is a heterogeneous disease in terms of presentation, duration, and severity. Due to this heterogeneity, it is difficult to align treatment decisions. Biomarkers have proved to be useful for the diagnosis and prognosis of many diseases, and over the years, many biomarkers have been propos...
Autores principales: | Kraaijvanger, Raisa, Janssen Bonás, Montse, Vorselaars, Adriane D. M., Veltkamp, Marcel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372102/ https://www.ncbi.nlm.nih.gov/pubmed/32760396 http://dx.doi.org/10.3389/fimmu.2020.01443 |
Ejemplares similares
-
The Role of Cutibacterium acnes in Sarcoidosis: From Antigen to Treatable Trait?
por: Kraaijvanger, Raisa, et al.
Publicado: (2022) -
Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study
por: Kahlmann, Vivienne, et al.
Publicado: (2020) -
Latent tuberculosis infection associates with cardiac involvement in patients with sarcoidosis
por: Beijer, Els, et al.
Publicado: (2020) -
Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients
por: Peters, Bas J. M., et al.
Publicado: (2021) -
Quantification of pulmonary disease activity in sarcoidosis measured with (18)F-FDG PET/CT: SUVmax versus total lung glycolysis
por: Schimmelpennink, Milou C., et al.
Publicado: (2019)